Patent ID: 9060939
Filing Date: 2015-06-23
Classification: A61K,A61P

Abstract:
1. A dosage form comprising tranexamic acid or a pharmaceutically acceptable salt thereof; and hydroxypropylmethylcellulose in an amount from about 5% to about 35% of the dosage form; wherein the dosage form is suitable for oral administration on a two or three times a day basis; wherein the dosage form provides a dose of about 650 mg of tranexamic acid; and wherein the dosage form provides an in vitro dissolution release rate of the tranexamic acid or pharmaceutically acceptable salt thereof, when measured by a USP 27 Apparatus Type II Paddle Method at 50 RPM in 900 ml water at 37±0.5° C., wherein from about 0 to about 40% by weight of the tranexamic acid or pharmaceutically acceptable salt thereof is released at about 15 minutes; and less than about 70% by weight tranexamic acid or pharmaceutically acceptable salt thereof is released at about 45 minutes.